Commercial-stage biopharmaceutical company focused on discovering and developing medicines for genetic diseases.
Pubblicita'
Pubblicita'
RBBIO
BridgeBio Pharma, Inc. rStock
73.64
16 set, 13:41 UTC
Circa
Info & Links
Sito Web
Contratti
- arbitrum-one:0x183…3cb7d
- morph-l2:0x4ca…2e24a
Continua a leggere
Informazioni da